Literature DB >> 2002430

Localization of interleukin-1 beta in human periodontal tissue.

J J Jandinski1, P Stashenko, L S Feder, C C Leung, W J Peros, J E Rynar, M J Deasy.   

Abstract

Interleukin-1 beta (IL-1 beta) is the predominant form of IL-1 produced by macrophages. IL-1 beta possesses numerous and diverse biological activities. Several of these activities, including fibroblast proliferation, potentiation of the immune response, and stimulation of bone resorption may be of relevance to the pathogenesis of periodontal disease. This study was designed to examine the presence of IL-1 beta in human periodontal tissue. An antiserum directed against the N-terminal segment (117-131) of human IL-1 beta was used to detect IL-1 beta using immunofluorescent staining techniques. IL-1 beta positive staining cells were observed in both normal and diseased tissue and were limited to the lamina propria. Brightly staining cells were increased by almost 3-fold in periodontally diseased tissue when compared to normal tissue. Low intensity staining cells were equally distributed in the normal and diseased specimens. We propose that IL-1 beta and IL-1 beta produced by cells in periodontal tissues may be related to the pathological processes associated with periodontal disease.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2002430     DOI: 10.1902/jop.1991.62.1.36

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  12 in total

1.  Interleukin-6 (IL-6) and IL-8 are induced in human oral epithelial cells in response to exposure to periodontopathic Eikenella corrodens.

Authors:  H Yumoto; H Nakae; K Fujinaka; S Ebisu; T Matsuo
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

Review 2.  Danger signals in oral cavity-related diseases.

Authors:  Jason G Kay; Jill M Kramer; Michelle B Visser
Journal:  J Leukoc Biol       Date:  2019-02-18       Impact factor: 4.962

3.  CD73-dependent adenosine dampens interleukin-1β-induced CXCL8 production in gingival fibroblasts: Association with heme oxygenase-1 and adenosine monophosphate-activated protein kinase.

Authors:  Erivan Schnaider Ramos-Junior; Michael Pedram; Renee E Lee; Drake Exstrom; Özlem Yilmaz; Robson Coutinho-Silva; David M Ojcius; Ana Carolina Morandini
Journal:  J Periodontol       Date:  2019-08-12       Impact factor: 6.993

4.  Interleukin-1 mRNA-expressing macrophages in human chronically inflamed gingival tissues.

Authors:  Y Matsuki; T Yamamoto; K Hara
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

5.  Activation of the interleukin-1beta precursor by Treponema denticola: a potential role in chronic inflammatory periodontal diseases.

Authors:  A Beauséjour; N Deslauriers; D Grenier
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

6.  Effect of different localizations of microgap on clinical parameters and inflammatory cytokines in peri-implant crevicular fluid: a prospective comparative study.

Authors:  A Duygu Boynueğri; Mehmet Yalim; Seçil Karakoca Nemli; B Imge Ergüder; Pelin Gökalp
Journal:  Clin Oral Investig       Date:  2011-01-07       Impact factor: 3.573

7.  Lipopolysaccharides of Bacteroides intermedius (Prevotella intermedia) and Bacteroides (Porphyromonas) gingivalis induce interleukin-8 gene expression in human gingival fibroblast cultures.

Authors:  M Tamura; M Tokuda; S Nagaoka; H Takada
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

Review 8.  The Impact of Peri-Implantitis on Systemic Diseases and Conditions: A Review of the Literature.

Authors:  Katherine Radaelli; Alice Alberti; Stefano Corbella; Luca Francetti
Journal:  Int J Dent       Date:  2021-05-15

Review 9.  The role of osteoimmunology in periodontal disease.

Authors:  Rayyan A Kayal
Journal:  Biomed Res Int       Date:  2013-09-17       Impact factor: 3.411

10.  Phospholipase A(2) Activity in Gingival Crevicular Fluid from Patients with Periodontal Disease: A possible Marker of Disease Activity.

Authors:  H Ishida; H Shinohara; T Nagata; S Nishikawa; Y Wakano
Journal:  Mediators Inflamm       Date:  1994       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.